via The Scientist RSS https://ift.tt/3pHE003 Sino Biological, Inc. (SZSE: 301047) has recently deposited reagents for the Omicron variant, including recombinant proteins to Spike and Nucleocapsid, and antibody products to BEI Resources, a central repository for reagents to support infectious disease research. https://ift.tt/eA8V8J December 31, 2021 at 09:31PM